Periasamy Selvaraj

Professor

Emory University

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Periasamy Selvaraj is a Professor at Emory University, located in the United States. His research focuses on cancer progression, tumor microenvironments, and innovative therapeutic approaches, as evidenced by his recent articles on tumor immunology and cancer treatment methodologies. His work also explores the intersection of virology and cancer therapy, particularly in the context of adoptive cell therapy and vaccine development.

Articles (10)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (7)

Ramireddy Bommireddy

Assistant Professor

Emory University School of Medicine

UNITED STATES

View details

SAng Moo Kang

University of Georgia

UNITED STATES

View details

Sanghoon Han

Jeju National University College of Medicine and Graduate School of Medicine

SOUTH KOREA

View details

Dong M. Shin

Professor

Emory University

UNITED STATES

View details

Mukesh Kumar

Assistant Professor

University of Georgia

UNITED STATES

View details

Rabindra Tirouvanziam

Emory University School of Medicine

UNITED STATES

View details

Haley Huang

Columbia University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Periasamy Selvaraj

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Chemoprevention of Head and Neck Cancer: A Review of Current Approaches and Future Perspectives

Beyond Cancer Cells: How the Tumor Microenvironment Drives Cancer Progression

Tumor-Intrinsic Enhancer of Zeste Homolog 2 Controls Immune Cell Infiltration, Tumor Growth, and Lung Metastasis in a Triple-Negative Breast Cancer Model

Hemagglutinin virus-like particles incorporated with membrane-bound cytokine adjuvants provide protection against homologous and heterologous influenza virus challenge in aged mice

The magic of small-molecule drugs during ex vivo expansion in adoptive cell therapy

Influenza Virus-like Particle-Based Hybrid Vaccine Containing RBD Induces Immunity against Influenza and SARS-CoV-2 Viruses

Dendritic cells pulsed with cytokine-adjuvanted tumor membrane vesicles inhibit tumor growth in her2-positive and triple negative breast cancer models

Expression of tdTomato and luciferase in a murine lung cancer alters the growth and immune microenvironment of the tumor

Metformin reduces PD-L1 on tumor cells and enhances the anti-tumor immune response generated by vaccine immunotherapy

Doxorubicin Conjugation to Reovirus Improves Oncolytic Efficacy in Triple-Negative Breast Cancer

Collaborators (7)

Ramireddy Bommireddy

SAng Moo Kang

Sanghoon Han

Dong M. Shin

Mukesh Kumar

Rabindra Tirouvanziam

Haley Huang

Make your next move.